首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study
【24h】

Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study

机译:超声引导的低功率微波消融治疗原发性乳头状微肝癌的长期疗效:3年的后续研究

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Purpose To evaluate the safety and efficacy of ultrasound-guided low-power microwave ablation (MWA) for the treatment of papillary thyroid microcarcinoma (PTMC) with a 3-year follow-up. Methods A total of 21 nodules diagnosed as PTMC from the 15 patients were performed with MWA at a power of 20?W. The images of the nodules were recorded by ultrasound before MWA and 1, 3, 6, 12?months after MWA, and every 6?months thereafter, respectively. The volumes of the nodules were compared before MWA and at each follow-up point after MWA. The volume reduction rate (VRR) of nodules was also calculated. Results The mean volume of the nodules was 134.3?±?129.8 mm_(3)initially (the range was 7.4–423.8 mm_(3)), which decreased significantly to 2.3?±?10.5 mm_(3)(the range was 0–48.1 mm_(3)) of the ablation area ( P ?=?0.000) at the follow-up point of 36?months with a mean VRR as 98.78?±?5.61% (the range was 74.28–100%). During the follow-up period (the range was 36–48 months), 20 of the 21 nodules were completely absorbed and no recurrent nodule was found. Conclusions After a long-term follow-up of 3?years, the low power MWA showed a good safety and efficacy for the treatment of PTMC. In addition to surgery and active surveillance, MWA might be another alternative for patients with PTMC.
机译:摘要目的,以评价超声引导的低功率微波消融(MWA)治疗乳头状甲状腺微癌(PTMC)的安全性和功效,为期3年的随访。方法使用来自15名患者的PTMC诊断为PTMC的总共21种结节以20μw的功率进行。在MWA和1,3,6,12℃之前的超声记录结节的图像,分别在MWA后的数月,此后每6个月。在MWA和MWA后的每次随访点之前比较结节的量。还计算了结节的体积减少率(VRR)。结果结节的平均体积为134.3?±129.8mm_(3)最初(范围为7.4-423.8 mm_(3)),其显着降低至2.3?±10.5 mm_(3)(范围为0- 48.1 mm_(3))消融区域(p?= 0.000)在36°的后续点,平均VRR为98.78?±5.61%(范围为74.28-100%)。在随访期间(范围为36-48个月),21种结节中的20个完全吸收,未发现复发结节。结论在3岁以下的长期随访3年后,低功率MWA对PTMC的治疗表现出良好的安全性和疗效。除了外科和主动监测外,MWA可能是PTMC患者的另一种选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号